| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |